发明名称 SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING INTEGRASE INHIBITOR
摘要 PROBLEM TO BE SOLVED: To provide compressed tablets for oral administration containing raltegravir in the form of a pharmaceutically acceptable salt.SOLUTION: The compressed tablets comprise: (A) an intragranular component comprising (i) an effective amount of an alkali metal salt of raltegravir, (ii) optionally a first superdisintegrant, and (iii) a binder; and (B) an extragranular component comprising (i) a second superdisintegrant, (ii) a filler, and (iii) a lubricant. Methods for preparing the tablets and the use of the tablets, optionally in combination with other anti-HIV agents, for the inhibition of HIV integrase, for the treatment or prophylaxis of HIV infection, or for the treatment, delay in the onset, or prophylaxis of AIDS are also described.SELECTED DRAWING: None
申请公布号 JP2016034962(A) 申请公布日期 2016.03.17
申请号 JP20150188605 申请日期 2015.09.25
申请人 MERCK SHARP & DOHME CORP 发明人 MAJID MAHJOUR;LI FENG;MA DECHENG;SUTTHILUG SOTTHIVIRAT
分类号 A61K31/513;A61K9/20;A61K9/24;A61K47/02;A61K47/10;A61K47/12;A61K47/32;A61K47/36;A61K47/38;A61P31/18;A61P43/00 主分类号 A61K31/513
代理机构 代理人
主权项
地址